Form 4 for CYTK CYTOKINETICS INC
Accepted 2026-03-18 00:00:00 ET · period of report 2026-03-17 · accession 0001061983-26-000028 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-18 | 2026-03-17 | CYTK | Callos Andrew | EVP, Chief Commercial Off | S - Sale | $62.15 | -8,542 | 71.6K | -11% | -$530.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-17 | S | D | 5,626 | $62.15 | 74,489 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-17 | S | D | 2,916 | $62.15 | 71,573 | D | — | — |